Minervax in a €22 million equity round backed by Trill Impact Ventures and Pureos Bioventures
10 December 2022
10 December 2022
Total investments received (USD): 166.09M
Round value (USD): 23.39M
Company: MinervaX
Industry: BiotechHealth services
Related deals
Phagos raised €25 million series A co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter, joined by Acurio, Citizen Capital, EF, Founders Capital.
Investments
01 October 2025
Light raised $30M in Series A funding led by Balderton Capital, joined by Atomico, Cherry Ventures, Seedcamp and Entrée Capital
Investments
14 September 2025
Arthex Biotech in a series B extension led by Bpifrance, now totalling $87 million
Investments
06 September 2025
Highlight Therapeutics raises €22.6M in a round led by Buenavista, joined by Advent Life Sciences, Columbus Venture Partners in Spain
Investments
04 September 2025
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Ireland
Italy